Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981342669> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2981342669 endingPage "S922" @default.
- W2981342669 startingPage "S921" @default.
- W2981342669 abstract "Epidermal growth factor receptor (EGFR) tyrosine kynase inhibitors (TKIs) remain the standard of care as first-line therapy for patients with non-small cell lung cancer (NSCLC) harboring an EGFR mutation. These drugs have been associated with improvements in both clinical outcomes and tolerability, compared with platinum-based chemotherapy. Three generations of TKIs are currently approved in the first-line setting, though only first (erlotinib and gefitinib) and second generation blockers (mainly afatinib, but also dacomitinib) have been extensively used in clinical practice nowadays. We reviewed 105 patients with NSCLC with advanced or recurrent stages that harbour EGFR mutations, treated with afatinib as first'line therapy among the academic hospitals adhered to the FAETT network. The information of clinical, pathological and treatment characteristics of the patients was collected retrospectively and the statistical analysis was performed with the software SPSS software version 21.0, considering the statistical significance if p-value <0.05. The characteristics of the patients are reflected in Table 1. The mean age at the beginning of treatment with afatinib was 61 (37-81) years. 48.6% of the patients were older than 65 years. 27.6% were older than 70 years. With a median follow-up of 15 months (0-82), the median progression-free survival was 14 months (10.74-17.26) Fig 1, and the median overall survival was 31 months (24.00) -37.99). The median PFS and OS among patients older than 65 years, and even those older than 70 years, is not statistically significant (14 vs 13 and 30 vs 31 months, repectively. P-value:0,83 and 0,78 On the other hand, the toxicities between both groups remain similar, with diarrhea and skin rash standing out as the most frequent, as reflected in the data published to date. Table 2View Large Image Figure ViewerDownload Hi-res image Download (PPT) This retrospective study shows no differences in the use of afatinib among older patients in terms of both efficacy and tolerability." @default.
- W2981342669 created "2019-11-01" @default.
- W2981342669 creator A5002789432 @default.
- W2981342669 creator A5006164153 @default.
- W2981342669 creator A5019628375 @default.
- W2981342669 creator A5027946288 @default.
- W2981342669 creator A5041419500 @default.
- W2981342669 creator A5048979897 @default.
- W2981342669 creator A5053919133 @default.
- W2981342669 creator A5055615948 @default.
- W2981342669 creator A5059718847 @default.
- W2981342669 creator A5070669622 @default.
- W2981342669 creator A5073917049 @default.
- W2981342669 creator A5075668387 @default.
- W2981342669 date "2019-10-01" @default.
- W2981342669 modified "2023-10-18" @default.
- W2981342669 title "EP1.01-28 Real World Use of Afatinib in NSCLC EGFRm+ Patients Outside Clinical Trials: A FAETT Experience" @default.
- W2981342669 doi "https://doi.org/10.1016/j.jtho.2019.08.2001" @default.
- W2981342669 hasPublicationYear "2019" @default.
- W2981342669 type Work @default.
- W2981342669 sameAs 2981342669 @default.
- W2981342669 citedByCount "0" @default.
- W2981342669 crossrefType "journal-article" @default.
- W2981342669 hasAuthorship W2981342669A5002789432 @default.
- W2981342669 hasAuthorship W2981342669A5006164153 @default.
- W2981342669 hasAuthorship W2981342669A5019628375 @default.
- W2981342669 hasAuthorship W2981342669A5027946288 @default.
- W2981342669 hasAuthorship W2981342669A5041419500 @default.
- W2981342669 hasAuthorship W2981342669A5048979897 @default.
- W2981342669 hasAuthorship W2981342669A5053919133 @default.
- W2981342669 hasAuthorship W2981342669A5055615948 @default.
- W2981342669 hasAuthorship W2981342669A5059718847 @default.
- W2981342669 hasAuthorship W2981342669A5070669622 @default.
- W2981342669 hasAuthorship W2981342669A5073917049 @default.
- W2981342669 hasAuthorship W2981342669A5075668387 @default.
- W2981342669 hasBestOaLocation W29813426691 @default.
- W2981342669 hasConcept C121608353 @default.
- W2981342669 hasConcept C126322002 @default.
- W2981342669 hasConcept C143998085 @default.
- W2981342669 hasConcept C197934379 @default.
- W2981342669 hasConcept C2776256026 @default.
- W2981342669 hasConcept C2778087573 @default.
- W2981342669 hasConcept C2778375690 @default.
- W2981342669 hasConcept C2779438470 @default.
- W2981342669 hasConcept C2780580887 @default.
- W2981342669 hasConcept C2780586478 @default.
- W2981342669 hasConcept C535046627 @default.
- W2981342669 hasConcept C65409693 @default.
- W2981342669 hasConcept C71924100 @default.
- W2981342669 hasConceptScore W2981342669C121608353 @default.
- W2981342669 hasConceptScore W2981342669C126322002 @default.
- W2981342669 hasConceptScore W2981342669C143998085 @default.
- W2981342669 hasConceptScore W2981342669C197934379 @default.
- W2981342669 hasConceptScore W2981342669C2776256026 @default.
- W2981342669 hasConceptScore W2981342669C2778087573 @default.
- W2981342669 hasConceptScore W2981342669C2778375690 @default.
- W2981342669 hasConceptScore W2981342669C2779438470 @default.
- W2981342669 hasConceptScore W2981342669C2780580887 @default.
- W2981342669 hasConceptScore W2981342669C2780586478 @default.
- W2981342669 hasConceptScore W2981342669C535046627 @default.
- W2981342669 hasConceptScore W2981342669C65409693 @default.
- W2981342669 hasConceptScore W2981342669C71924100 @default.
- W2981342669 hasIssue "10" @default.
- W2981342669 hasLocation W29813426691 @default.
- W2981342669 hasOpenAccess W2981342669 @default.
- W2981342669 hasPrimaryLocation W29813426691 @default.
- W2981342669 hasRelatedWork W1994508061 @default.
- W2981342669 hasRelatedWork W2049303357 @default.
- W2981342669 hasRelatedWork W2186047679 @default.
- W2981342669 hasRelatedWork W2542769082 @default.
- W2981342669 hasRelatedWork W2810945895 @default.
- W2981342669 hasRelatedWork W2888534976 @default.
- W2981342669 hasRelatedWork W2906574801 @default.
- W2981342669 hasRelatedWork W3042289395 @default.
- W2981342669 hasRelatedWork W3175282903 @default.
- W2981342669 hasRelatedWork W4281690819 @default.
- W2981342669 hasVolume "14" @default.
- W2981342669 isParatext "false" @default.
- W2981342669 isRetracted "false" @default.
- W2981342669 magId "2981342669" @default.
- W2981342669 workType "article" @default.